NCT06071442View on ClinicalTrials.gov

Potential Drug Interaction Study Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel/Ethinyl Estradiol-containing Oral Contraceptives, and Carbamazepine

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 17, 2024

Primary Completion Date

April 12, 2024

Study Completion Date

April 12, 2024

Conditions
Healthy Participants
Interventions
DRUG

Vemircopan

Participants will receive oral tablets of Vemircopan.

DRUG

Rosuvastatin

Participants will receive oral coated tablets of Rosuvastatin.

DRUG

Metformin

Participants will receive oral film-coated tablets of Metformin.

DRUG

Levonorgestrel / Ethinyl Estradiol

Participants will receive oral tablets of Levonorgestrel/ Ethinyl Estradiol.

DRUG

Carbamazepine

Participants will receive oral chewable tablets of Carbamazepine.

Trial Locations (1)

21225

Research Site, Brooklyn

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY